Cross-sectional studycited by the Tayebat archiveabstract only checked A-PPI-10 standard review

PPIs and low magnesium (Rotterdam)

Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.

Overview

Kieboom BC et al.. Am J Kidney Dis 2015 · PMID 26123862 · DOI 10.1053/j.ajkd.2015.05.012

PPI users had twice the odds of low magnesium, especially with long use and loop diuretics.

Does the study support the specific claim? Yes · Methodological quality: moderate

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Mg and PPIs.

How was the study done?

Population cohort.

How many people, animals or samples were studied?

9,818.

What was actually found?

Higher odds of low Mg.

How large was the observed effect?

OR 2.00.

What do the results mean in everyday life?

Check Mg with diuretics.

What are the study's limitations?

Single measurement.

What does it say about Elawady's specific claim?

Supports.

Do the results apply to Germany and Europe?

Dutch data.

What can explicitly not be concluded from this study?

Causation.

Scientific in-depth review

1. Full reference

Authors
Kieboom BC, Kiefte-de Jong JC, Eijgelsheim M, Franco OH, Kuipers EJ, Hofman A, Zietse R, Stricker BH, Hoorn EJ
Journal
Am J Kidney Dis
Year
2015
Identifier
PMID 26123862 DOI 10.1053/j.ajkd.2015.05.012
Verification
verified – PubMed E-utilities efetch, 2026-10-25
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

not stated in abstract

2. Research question

Is PPI use associated with hypomagnesaemia in the general population?

3. Study design and population

Study design
Cross-sectional study – Population-based cohort (Rotterdam Study), cross-sectional analysis of serum magnesium
Population

General population ≥45

Country

Netherlands

Period

Rotterdam Study

Sample size

9,818

Inclusion and exclusion criteria

see abstract

4. Methods and endpoints

Exposure / intervention

PPI use; H2RA use

Comparator

No use

Endpoints

Serum Mg; hypomagnesaemia ≤1.44 mEq/L

Statistical methods

Adjusted regression

5. Actual results

Results

Serum Mg −0.022 mEq/L in PPI users; hypomagnesaemia OR 2.00 (1.36–2.93); with loop diuretics OR 7.22 (1.69–30.83); prolonged use OR 2.99 (1.73–5.15); H2RA OR 2.00 (1.08–3.72).

Absolute risks

not reported in abstract

Authors' conclusion

PPI use is associated with hypomagnesaemia in the general population, stronger with prolonged use and loop diuretics.

6. Strengths

  • Population-based
  • Adjusted for kidney function and diuretics

7. Weaknesses

  • Single Mg measurement
  • Cross-sectional
  • Few cases (n=36)

8. Risk of bias

Orienting tool
ROBINS-E
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
some concerns
Rationale

Small case numbers; cross-sectional.

9. Assessment of the statistical interpretation

Modest relative risks from observational data; see bias notes.

10. Relevance to the specific claim

C-PPI-03.

11. Independent contrary findings

Absolute Mg difference small.

12. Transferability to Germany and Europe

High: European (Swedish, UK, Dutch, German) data show similar associations; PPIs are widely used in Germany.

13. Overall methodological judgement

Credible association; absolute effect small.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitymoderate
Risk of biassome concerns
Precision of resultslow
Directnessdirect
Reproducibilitypartly replicated
Consistency with the overall evidenceconsistent
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)essentially correct but incomplete

14. Open questions

15. Linked fact checks

Use by the Tayebat archive

Note: according to the archive, the studies were compiled by the archive operators. Whether Dr. Elawady himself cited this study is not established.

What the archive says about the study

Listed in the archive bibliography of the acid-blockers rule without its own interpretation; used implicitly to support the rule summary ('long-term suppression turns against the body: CKD, bacterial overgrowth, C. difficile, pneumonia, B12 and magnesium deficiency, hip fractures, microbiome change, excess mortality').

A. What was actually studied?

Is PPI use associated with hypomagnesaemia in the general population?

B. What did the authors find?

Serum Mg −0.022 mEq/L in PPI users; hypomagnesaemia OR 2.00 (1.36–2.93); with loop diuretics OR 7.22 (1.69–30.83); prolonged use OR 2.99 (1.73–5.15); H2RA OR 2.00 (1.08–3.72).

C. What conclusions do the authors themselves draw?

PPI use is associated with hypomagnesaemia in the general population, stronger with prolonged use and loop diuretics.

D. What does the archive derive from it?

Supports magnesium part.

E. Is this derivation scientifically justified?

Yes as association.

Adequacy of the interpretation (by the archive)
essentially correct but incomplete